Oct. 15 Recursion Pharmaceuticals, Inc. Announces Sanofi Options Potential First-In-Class Immunology Development Candidate From Their Collaboration CI Oct. 15 Recursion Prices $200 Million Stock ...

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) — Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development ...

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...

POPULARITAS.COM — Aceh memiliki kekayaan hutan dan ekosistem yang penting, mulai dari kawasan Leuser dan Ulu Masen hingga hutan gambut dan mangrove. Untuk itu , menjadi penting upaya menjaga hutan ...

TEROPONGNEWS.COM, MERAUKE – Pemerintah Provinsi Papua Selatan mendapatkan alokasi dana sebesar Rp26,8 miliar melalui program Result-Based Payment (RBP) REDD+ Green Climate Fund (GCF) untuk mendukung ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about their dangers. Most recently, its executives wrote about the threat posed by ...